Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Promoter methylation of sFRP5 in patients with ovarian clear cell adenocarcinoma

17 Mar 2010

Abstract excerpt

BACKGROUND: Specific tumour suppressor genes with promoter methylation in ovarian clear cell adenocarcinoma (OCCA) can be one important epigenetic mark distinguishing OCCA from ovarian serous adenocarcinoma (OSA), benign endometriotic cysts and normal ovarian epitheliums. MATERIALS AND METHODS: Five OCCA cell lines, 63 cancer tissues (48 OCCA and 15 OSA), 10 benign endometriotic cysts and five normal ovarian...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Epigenetics and DNA Methylation
Share to Kruppel-like factors research
Share to Ovarian cancer diagnosis and treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 20486992
DOI: 10.1111/j.1365-2362.2010.02266.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Promoter methylation of sFRP5 in patients with ovarian clear cell adenocarcinomaPMID 20486992Read ↗

Promoter Methylation status of HIN-1 associated with outcomes of ovarian clear cell adenocarcinomaSemantic proximity Read ↗

Epigenetic silencing of SFRP5 is related to malignant phenotype and chemoresistance of ovarian cancer through Wnt signaling pathway.Semantic proximity Read ↗

Comprehensive genomic profiling (CGP) of ovarian clear cell carcinomas (OCCC) identifies clinically relevant genomic alterations (CRGA) and targeted therapy optionsSemantic proximity Read ↗

Prognostic Significance of SLFN11 Methylation in Plasma Cell-Free DNA in Advanced High-Grade Serous Ovarian CancerSemantic proximity Read ↗

Genomic characterization of Chinese ovarian clear cell carcinoma identifies driver genes by whole exome sequencing.Semantic proximity Read ↗

Loss of secreted frizzled-related protein 4 correlates with an aggressive phenotype and predicts poor outcome in ovarian cancer patients.Semantic proximity Read ↗

Identification of Novel Epigenetic Markers for Clear Cell Renal Cell CarcinomaSemantic proximity Read ↗

<i>WT1</i> and <i>WT1‐AS</i> genes are inactivated by promoter methylation in ovarian clear cell adenocarcinomaSemantic proximity Read ↗

LINE-1 ORF1p expression occurs in clear cell ovarian carcinoma precursors and is a candidate blood biomarkerSemantic proximity Read ↗

Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma.Semantic proximity Read ↗

Somatic mutations of PPP2R1A in ovarian and uterine carcinomas.Semantic proximity Read ↗

Whole-genome sequencing revealed novel prognostic biomarkers and promising targets for therapy of ovarian clear cell carcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.